Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181411 | 0.93 | PRKCA (0.42) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL29407027 | 0.90 | LMNA (0.45) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL181495 | 0.87 | ALDH1A1 (0.41) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL181837 | 0.86 | TDP1 (0.38) | PRKCALMNAALDH1A1TDP1HSD17B10 | |
| SCHEMBL13387855 | 0.83 | LMNA (0.39) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL181439 | 0.83 | LMNA (0.39) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL2402716 | 0.82 | LMNA (0.50) | PRKCALMNAALDH1A1TDP1PRKCE | |
| SCHEMBL8862928 | 0.82 | TDP1 (0.47) | LMNAALDH1A1TDP1HSD17B10MAPT | |
| SCHEMBL8843127 | 0.82 | TDP1 (0.47) | LMNAALDH1A1TDP1HSD17B10MAPT | |
| SCHEMBL8863004 | 0.82 | TDP1 (0.47) | LMNAALDH1A1TDP1HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637804-B2 | Ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12637578-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12630728-B2 | Ink set and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12629934-B2 | Recording method and recording device | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12630973-B2 | Recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260125850-A1 | Pretreatment Liquid For Textile Printing And Textile Printing Method | SEIKO EPSON CORP (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20260116073-A1 | Maintenance Method And Recording Apparatus | SEIKO EPSON CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12576648-B2 | Ink jet recording device | SEIKO EPSON CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12576663-B2 | Treatment method | SEIKO EPSON CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12545800-B2 | Reaction liquid for pigment printing, ink set, and recording method | SEIKO EPSON CORPORATION (JP) | 2026-02-10 | — | — | US | disclosed |
| US-7604695-B2 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2009-10-20 | — | — | US | disclosed |
| EP-2083054-A1 | NONAQUEOUS INKJET INK AND INK SET | Toyo Ink Mfg. Co. Ltd. (JP) | 2009-07-29 | — | — | EP | disclosed |
| US-7407536-B2 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2008-08-05 | — | — | US | disclosed |
| EP-1790700-B1 | Organic solvent based ink Composition | TOYO INK MFG CO (JP) | 2008-07-02 | — | — | EP | disclosed |
| CN-1974683-A | Ink composition | TOYO INK MFG CO (JP) | 2007-06-06 | — | — | CN | disclosed |
| CN-1974684-A | Ink composition | TOYO INK MFG CO (JP) | 2007-06-06 | — | — | CN | disclosed |
| US-20070119342-A1 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070119335-A1 | For printing on non-absorbable printing media, containing as a solvent a a hydrofuran-3-one, hydropyranone, oxazolinone, morpholin-3-one or 1,3-hydrooxazin-4-one; odorless, excellent safety and health properties, resin solubility, printing stability and drying properties and causes no corrosion | TOYO INK MFG. CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1790700-A1 | Organic solvent based ink Composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-30 | — | — | EP | disclosed |
| EP-1790699-A1 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125850-A1 | Pretreatment Liquid For Textile Printing And Textile Printing Method | ADH1A, RARA, RBP4 | PRKCA 437/4885LMNA 494/4885ALDH1A1 38/4885 |
| US-12576663-B2 | Treatment method | EPCAM, FLNA, TAS2R8 | PRKCA 3127/4885LMNA 2746/4885ALDH1A1 487/4885 |
| US-12637578-B2 | Ink jet ink composition and recording method | TYR, RB1, WNT1 | PRKCA 2263/4885LMNA 4399/4885ALDH1A1 963/4885 |
| US-12630973-B2 | Recording method | DOT1L, EMD, EZH2 | PRKCA 3328/4885LMNA 358/4885ALDH1A1 788/4885 |
| US-12576648-B2 | Ink jet recording device | L1CAM, PRDM9, KCNJ2 | PRKCA 3267/4885LMNA 1956/4885ALDH1A1 726/4885 |
| US-20260116073-A1 | Maintenance Method And Recording Apparatus | WFS1, HCN2, SMN1; SMN2 | PRKCA 4133/4885LMNA 1289/4885ALDH1A1 1395/4885 |
| US-12629934-B2 | Recording method and recording device | HCN2, MC1R, TYR | PRKCA 3850/4885LMNA 519/4885ALDH1A1 404/4885 |
| US-12545800-B2 | Reaction liquid for pigment printing, ink set, and recording method | PARN, PARG, TYR | PRKCA 1029/4885LMNA 1384/4885ALDH1A1 373/4885 |
| US-12630728-B2 | Ink set and recording method | DOT1L, SET, ALKBH3 | PRKCA 3387/4885LMNA 1607/4885ALDH1A1 44/4885 |
| US-12637804-B2 | Ink jet recording method | IK, PRPH, SLC6A19 | PRKCA 2402/4885LMNA 3315/4885ALDH1A1 2683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.